Skip to content
Search
 
Search
EN  
  • ES
  • DE
  • ZH
   
  • Company
  • Innovation
  • Sustainability
  • Products and services
  • Investors
  • Careers
  • Media
  • Partners
  • Contact
 

Company

Since 1909, Grifols has worked to improve the health and well-being of people around the world.

Read more

  • What we do
    • Biopharma
      • From donors to patients
      • Plasma journey
    • Diagnostic
    • Bio Supplies
    • Healthcare Solutions for Hospitals
  • Mission and values
  • Ethics and compliance
  • Grifols Engineering
    • Engineering
      • Project Management
      • Biotech Processes
      • General Processes
    • Machinery
      • Tailor-made Solutions
      • Pharmaceutical Robotics
      • Standardized Processes
    • Consulting
    • Contact
  • Our history
  • Grifols museum
    • La Casa: where it all began
    • The Plant: people helping people
    • The World: From family business to global company
  • Grifology
    • The Cabinet

Every action we take is motivated by our mission to improve people's lives.

Read more

Our unique and remarkable history combines scientific expertise with a desire to serve patients and society.

Read more

We develop, produce and market innovative medicines, solutions and services in more than 110 countries.

Read more

 

Innovation

Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.  

Read more

  • Plasma Powerhouse
  • Beyond plasma
  • Key therapeutic areas
    • Immunology
    • Hepatology and Intensive Care
    • Pulmonology
    • Hematology
    • Neurology
      • AMBAR®: Research in Alzheimer's Disease
      • AMBAR® Clinical program
    • Infectious Diseases
    • Further Therapeutic Opportunities
  • Extending our innovative reach
    • Team up with Grifols Innovation and New Technologies
    • Scientific Awards and Programs
  • Connecting knowledge - Our R&D network

We apply our growing knowledge of plasma to change healthcare.

Read more

Our treatments are enhancing people’s well-being and quality of life.

Read more

We’re drawing on a broad scientific base to continue innovating.

Read more

 

Sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

Read more

  • Commitment to donors and patients
    • Supporting donors
    • Supporting patients
  • Impact on society
  • Our people
  • The environment
  • Ethical leadership
  • Sustainability Reports

2022 Sustainability Report: a detailed overview of our sustainability strategy, actions and progress

Read

Patients drive the work we do every day. We support patients and patient associations.

Learn more

As mindful stewards of the environment we are resolved to fight climate change.

Read more

 
 

Investors

Read more

  • Stock information
    • Stock and share capital
    • Dividends
    • Major holders and treasury stock
    • Agreements between shareholders
    • Analyst coverage
  • Financials
    • Financial results
    • Annual accounts
    • Fixed income and credit ratings
    • Average period of payment to suppliers
  • Press releases
  • Presentations and events
  • Agenda
  • Communications with regulators (CNMV/SEC)
    • CNMV
    • SEC
    • Other relevant information
    • Inside information
    • Relevant events up to Dec. 31st, 2019
  • Corporate Stewardship Reports
  • Corporate governance
    • Board of Directors
      • Committees
      • Regulations
    • General Shareholders’ Meeting
    • Annual corporate governance report
    • Directors' remuneration report
    • Articles of association
    • Corporate policies
  • Mergers
  • Biotest: voluntary takeover offer |
    Freiwilliges übernahmeangebot

Here you can read our Q2 2023 financial results

Read results

Please click here to listen to the webcast of our Q2 2023 financial results

Listen to the webcast

The 2022 Integrated and Sustainability Annual Report is now available

Read more

 

Careers

People are at the heart of our business. We are committed to continued investment in training and development.

Read more

  • Training and development
 

Media

Latest news about the company and contact information for journalists and communication professionals.

Read more

  • Media contacts
  • Newsroom
  • Media Center
 
 

Contact

Read more

  • International Headquarters
  • Adverse reactions – Pharmacovigilance
  • Grifols Ethics Helpline
Search
Show menu
   
Search
com.grifols.labels.close-menu
Company   Innovation   Sustainability   Products and services Investors   Careers   Media   Partners Contact  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Company What we do   Mission and values Ethics and compliance Grifols Engineering   Our history Grifols museum   Grifology  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
What we do Biopharma   Diagnostic Bio Supplies Healthcare Solutions for Hospitals
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Biopharma From donors to patients Plasma journey
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Diagnostic
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Bio Supplies
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Healthcare Solutions for Hospitals
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Mission and values
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Ethics and compliance
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols Engineering Engineering   Machinery   Consulting Contact
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Engineering Project Management Biotech Processes General Processes
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Machinery Tailor-made Solutions Pharmaceutical Robotics Standardized Processes
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Consulting
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Contact
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Our history
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols museum La Casa: where it all began The Plant: people helping people The World: From family business to global company
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
La Casa: where it all began
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
The Plant: people helping people
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
The World: From family business to global company
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifology The Cabinet
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
The Cabinet
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Innovation Plasma Powerhouse Beyond plasma Key therapeutic areas   Extending our innovative reach   Connecting knowledge - Our R&D network
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Plasma Powerhouse
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Beyond plasma
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Key therapeutic areas Immunology Hepatology and Intensive Care Pulmonology Hematology Neurology   Infectious Diseases Further Therapeutic Opportunities
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Immunology
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Hepatology and Intensive Care
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Pulmonology
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Hematology
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Neurology AMBAR®: Research in Alzheimer's Disease AMBAR® Clinical program
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Infectious Diseases
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Further Therapeutic Opportunities
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Extending our innovative reach Team up with Grifols Innovation and New Technologies Scientific Awards and Programs
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Team up with Grifols Innovation and New Technologies
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Scientific Awards and Programs
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Connecting knowledge - Our R&D network
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Sustainability Commitment to donors and patients   Impact on society   Our people The environment Ethical leadership Sustainability Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Commitment to donors and patients Supporting donors Supporting patients  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Supporting donors
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Supporting patients
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Impact on society
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Our people
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
The environment
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Ethical leadership
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Sustainability Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Products and services
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Investors Stock information   Financials   Press releases Presentations and events Agenda Communications with regulators (CNMV/SEC)   Corporate Stewardship Reports Corporate governance   Mergers Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Stock information Stock and share capital   Dividends Major holders and treasury stock Agreements between shareholders Analyst coverage
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Stock and share capital
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Dividends
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Major holders and treasury stock
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Agreements between shareholders
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Analyst coverage
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Financials Financial results Annual accounts Fixed income and credit ratings Average period of payment to suppliers
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Financial results
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Annual accounts
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Fixed income and credit ratings
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Average period of payment to suppliers
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Press releases
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Presentations and events
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Agenda
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Communications with regulators (CNMV/SEC) CNMV SEC Other relevant information Inside information Relevant events up to Dec. 31st, 2019
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
CNMV
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
SEC
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Other relevant information
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Inside information
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Relevant events up to Dec. 31st, 2019
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Corporate Stewardship Reports
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Corporate governance Board of Directors   General Shareholders’ Meeting   Annual corporate governance report Directors' remuneration report Articles of association Corporate policies
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Board of Directors Committees Regulations
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
General Shareholders’ Meeting
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Annual corporate governance report
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Directors' remuneration report
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Articles of association
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Corporate policies
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Mergers
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Careers Training and development
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Training and development
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media Media contacts Newsroom Media Center  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media contacts
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Newsroom
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Media Center
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Partners
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Contact International Headquarters Adverse reactions – Pharmacovigilance Grifols Ethics Helpline
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
International Headquarters
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Adverse reactions – Pharmacovigilance
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Grifols Ethics Helpline
English  
  • Spanish
  • German
  • Chinese

Follow

INSIDE INFORMATION

Inside Information

GRIFOLS, S.A. guarantees that the texts published in this page correspond exactly and entirely with the texts sent to the CNMV by the Company or by third parties. All the communications are available in the Web page of the CNMV.

Previous
2023 2021 2020
Next

2023


June 14, 2023
Grifols announces a potential transaction in China involving Shanghai RAAS

2021


October 26, 2021
Grifols earns approval for the voluntary public tender offer of Biotest


September 17, 2021
Grifols acquires Tiancheng Pharmaceutical Holding, the largest shareholder of Biotest


September 17, 2021
Presentation of Grifols' investment in Biotest and call details to analysts and investors

2020


June 8, 2020
COVID-19 Impacts


March 27, 2020
Grifols and Shanghai RAAS close their strategic alliance in China


March 25, 2020
Grifols has entered into a formal collaboration with U.S. healthcare agencies to produce a treatment to treat COVID-19

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

Follow

© 2023 Grifols, S.A. All rights reserved worldwide.

ABOUT US

Company

Sustainability

Innovation

Products & services

Investors

Careers

Media

TOP WEBSITES

Grifols Plasma

The Grifols Academy of Plasmapheresis

Grifols Scientific Awards

Grifols Engineering

Grifols Egypt for Plasma Derivatives

Victor Grifols i Lucas Foundation

Probitas Foundation

J.A. Grifols Foundation

HELP

Privacy notices

Cookies policy

Cookie Settings

Terms of use

Contact

Glossary

© 2023 Grifols, S.A. All rights reserved worldwide.